Acro Biomedical (ACBM) Other Accumulated Expenses (2022 - 2025)

Acro Biomedical has reported Other Accumulated Expenses for 4 years, with the latest figure at $1100.0 in Q4 2025.

• For the quarter ending Q4 2025, Other Accumulated Expenses changed 0.0% year-over-year to $1100.0; the trailing twelve-month figure through Dec 2025 stood at $1100.0 (changed 0.0% YoY), and the FY2025 full-year result was $1100.0, changed 0.0% from the prior year.
• Other Accumulated Expenses for Q4 2025 stood at $1100.0, roughly flat from $1100.0 in the prior quarter.
• The five-year high for Other Accumulated Expenses was $79078.0 in Q3 2023, with the low at $1100.0 in Q4 2023.
• Average Other Accumulated Expenses over 4 years is $40029.0, with a median of $39963.0 recorded in 2022.
• Year-over-year, Other Accumulated Expenses plunged 98.6% in 2023 and changed 0.0% in 2024.
• Tracing ACBM's Other Accumulated Expenses over 4 years: stood at $78826.0 in 2022, then sank by 98.6% to $1100.0 in 2023, then changed by 0.0% to $1100.0 in 2024, then changed by 0.0% to $1100.0 in 2025.
• The last three Other Accumulated Expenses figures came in at $1100.0 (Q4 2025), $1100.0 (Q4 2024), and $1100.0 (Q4 2023), per Business Quant data.

Peer Comparison